Wealth Enhancement Advisory Services LLC Acquires 26,748 Shares of DENTSPLY SIRONA Inc. (NASDAQ:XRAY)

Wealth Enhancement Advisory Services LLC raised its stake in shares of DENTSPLY SIRONA Inc. (NASDAQ:XRAY - Free Report) by 222.2% during the 4th quarter, according to the company in its most recent filing with the SEC. The firm owned 38,786 shares of the medical instruments supplier's stock after purchasing an additional 26,748 shares during the quarter. Wealth Enhancement Advisory Services LLC's holdings in DENTSPLY SIRONA were worth $736,000 as of its most recent filing with the SEC.

Other large investors have also made changes to their positions in the company. Bank of New York Mellon Corp boosted its holdings in shares of DENTSPLY SIRONA by 27.9% in the 4th quarter. Bank of New York Mellon Corp now owns 2,403,110 shares of the medical instruments supplier's stock worth $45,611,000 after acquiring an additional 523,692 shares in the last quarter. Charles Schwab Investment Management Inc. grew its position in shares of DENTSPLY SIRONA by 1.7% during the 4th quarter. Charles Schwab Investment Management Inc. now owns 2,101,133 shares of the medical instruments supplier's stock worth $39,880,000 after buying an additional 35,360 shares during the period. Entropy Technologies LP bought a new stake in DENTSPLY SIRONA in the fourth quarter valued at approximately $630,000. First Eagle Investment Management LLC lifted its holdings in DENTSPLY SIRONA by 2.5% during the fourth quarter. First Eagle Investment Management LLC now owns 14,500,409 shares of the medical instruments supplier's stock worth $275,218,000 after acquiring an additional 348,532 shares in the last quarter. Finally, Choreo LLC boosted its holdings in shares of DENTSPLY SIRONA by 191.6% in the fourth quarter. Choreo LLC now owns 23,507 shares of the medical instruments supplier's stock valued at $440,000 after buying an additional 15,446 shares during the period. Institutional investors and hedge funds own 95.70% of the company's stock.

Wall Street Analyst Weigh In

XRAY has been the topic of a number of recent research reports. UBS Group lowered their target price on DENTSPLY SIRONA from $27.00 to $25.00 and set a "buy" rating on the stock in a research report on Friday, May 9th. Needham & Company LLC reissued a "hold" rating on shares of DENTSPLY SIRONA in a research note on Thursday, March 13th. Mizuho lowered their target price on shares of DENTSPLY SIRONA from $21.00 to $18.00 and set a "neutral" rating on the stock in a report on Thursday, March 13th. Robert W. Baird cut their price target on shares of DENTSPLY SIRONA from $22.00 to $20.00 and set a "neutral" rating for the company in a research note on Friday, February 28th. Finally, Morgan Stanley cut shares of DENTSPLY SIRONA from an "overweight" rating to an "equal weight" rating and set a $14.00 target price on the stock. in a report on Tuesday, April 15th. Eleven equities research analysts have rated the stock with a hold rating and three have given a buy rating to the stock. Based on data from MarketBeat, the company has a consensus rating of "Hold" and a consensus target price of $20.36.

DENTSPLY SIRONA Stock Performance

NASDAQ:XRAY traded down $0.38 during mid-day trading on Friday, reaching $15.63. 1,408,937 shares of the company's stock were exchanged, compared to its average volume of 2,963,084. The business's fifty day simple moving average is $14.79 and its two-hundred day simple moving average is $16.88. DENTSPLY SIRONA Inc. has a one year low of $12.16 and a one year high of $27.95. The firm has a market capitalization of $3.11 billion, a PE ratio of -7.55, a price-to-earnings-growth ratio of 1.80 and a beta of 0.95. The company has a debt-to-equity ratio of 0.72, a quick ratio of 0.84 and a current ratio of 1.25.

DENTSPLY SIRONA (NASDAQ:XRAY - Get Free Report) last issued its quarterly earnings results on Thursday, May 8th. The medical instruments supplier reported $0.43 EPS for the quarter, topping analysts' consensus estimates of $0.29 by $0.14. DENTSPLY SIRONA had a positive return on equity of 12.62% and a negative net margin of 10.59%. The company had revenue of $879.00 million for the quarter, compared to analysts' expectations of $854.75 million. During the same quarter last year, the business earned $0.42 earnings per share. DENTSPLY SIRONA's revenue was down 7.8% on a year-over-year basis. Analysts anticipate that DENTSPLY SIRONA Inc. will post 1.84 earnings per share for the current fiscal year.

DENTSPLY SIRONA Announces Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Friday, July 11th. Investors of record on Friday, June 27th will be paid a $0.16 dividend. This represents a $0.64 annualized dividend and a yield of 4.09%. The ex-dividend date is Friday, June 27th. DENTSPLY SIRONA's dividend payout ratio (DPR) is presently -14.10%.

DENTSPLY SIRONA Profile

DENTSPLY SIRONA Inc manufactures and sells various dental products and technologies worldwide. It operates in four segments: Connected Technology Solutions, Essential Dental Solutions, Orthodontic and Implant Solutions, and Wellspect Healthcare. The company offers dental equipment comprising imaging equipment, motorized dental handpieces, treatment centers, other instruments, amalgamators, mixing machines, and porcelain furnaces; and dental CAD/CAM technologies to support dental restorations, such as intraoral scanners, 3-D printers, mills, other software and services, and a full-chairside economical restoration of esthetic ceramic dentistry, as well as DS Core, its cloud-based platform.